Reuters - The first new treatment in a half-century for the autoimmune disease lupus won U.S. approval on Wednesday. The drug, Benlysta from Human Genome Sciences Inc, is given once a month by intravenous infusion.
Source: http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/nm/20110310/hl_nm/us_humangenome_lupus_disease
iphone 4 reviews iphone 5 rumors iphone4g
Keine Kommentare:
Kommentar veröffentlichen